Axonal pathology in myelin disorders (original) (raw)
References
Aguayo, A., Attiwell, M., Trecarten, J., Perkins, S. & Bray, G. (1977) Abnormal myelination in transplanted Trembler mouse Schwann cells. Na ture265, 73–75. Google Scholar
Anderson, T. J., Schneider, A., Barrie, J. A., Klugmann, M., Mcculloch, M. C., Kirkham, D., Kyriakides, E., Nave, K.-A. & Griffiths, I. R. (1998) Late-onset neurodegeneration in mice with increased dosage of the proteolipid protein gene. Journal of Comparative Neurology394, 506–519. Google Scholar
Anzini, P., Neuberg, D. D.-H., Schachner, M., Nelles, E., Willecke, K., Zielasek, J., Toyka, K. V., Suter, U. & Martini, R. (1997) Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32. Journal of Neuroscience17, 4545–4551. Google Scholar
Arnold, D. L., Reiss, G. T., Matthews, P. M., Francis, G. S., Collins, D. L., Wolfson, C. & Antel, J. P. (1994) Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Annals of Neurology36, 76–82. Google Scholar
Arquint, M., Roder, J., Chia, L.-S., Down, J., Wilkinson, O., Bayley, H., Braun, P. & Dunn, R. (1987) Molecular cloning and primary structure of myelin-associated glycoproteins. Proceedings of the National Academy of Sciences (USA)84, 600–604. Google Scholar
Barnes, D., Munro, P. M. G., Youl, B. D., Prineas, J. W. & Mcdonald, W. I. (1991) The longstandingMS lesion. Brain114, 1271–1280. Google Scholar
Bell, J. I. & Lathrop, G. M. (1996) Multiple loci for multiple sclerosis. Nature Genetics13, 377–378. Google Scholar
Bergoffen, J., Scherer, S. S., Wang, S., Oronzi scott, M., Bone, L. J., Paul, D. L., Chen, K., Lensch, M. W., Chance, P. F. & Fischbeck, K. H. (1993) Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science262, 2039–2042. Google Scholar
Bjartmar, C., Rudick, R., MÖrk, S. & Trapp, B. D. (1999) Axonal transection in multiple sclerosis [abstract]. Journal of Neurochemistry72, S40. Google Scholar
Bradley, W. G. (1987) Recent viewsonamyotrophic lateral sclerosis with emphasis on electrophysiological studies. Muscle Nerve10, 490–502. Google Scholar
Brown, A., Mcfarlin, D. E. & Raine, C. S. (1982) Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse. Laboratory Investigation46, 171–185. Google Scholar
BÖ, L., MÖrk, S., Kong, P. A., Nyland, H., Pardo, C. A. & Trapp, B. D. (1994) Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. Journal of Neuroimmunology51, 135–146. Google Scholar
Catterall, W. A. (1984) The molecular basis of neuronal excitability. Science223, 653–661. Google Scholar
Charcot, M. (1868) Histologie de le sclerose en plaques. Gazette Hopitaux141, 554–558. Google Scholar
Colello, R. J. & Pott, U. (1997) Signals that initiate myelination in the developing mammalian nervous system. Molecular Neurobiology15, 83–100. Google Scholar
Collins, B. E., Yang, L. J.-S., Mukhopadhyay, G., Filbin, M. T., Kiso, M., Hasegawa, A. & Schnaar, R. L. (1997) Sialic acid specificity of myelinassociated glycoprotein binding. Journal of Biological Chemistry272, 1248–1255. Google Scholar
Davie, C. A., Hawkins, C. P., Barker, G. J., Brennan, A., Tofts, P. S., Miller, D. H. & McDonald, W. I. (1994) Serial proton magnetic resonance spectroscopy in acute multiple sclerois lesions. Brain117, 49–58. Google Scholar
Davie, C. A., Barker, G. J., Webb, S., Tofts, P. S., Thompson, A. J., Harding, A. E., Mcdonald, W. I. & Miller, D. H. (1995) Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain118, 1583–1592. Google Scholar
De Stefano, N., Matthews, P. M., Antel, J. P., Preul, M., Francis, G. & Arnold, D. L. (1995) Chemical pathology of acute demyelinating lesions and its correlation with disability. Annals of Neurology38, 901–909. Google Scholar
De Stefano, N., Matthews, P. M., Fu, L., Narayanan, S., Stanley, J., Francis, G. S., Antel, J. P. & Arnold, D. L. (1998) Axonal damage correlates with disability in patients with relapsingremitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain121, 1469–1477. Google Scholar
De waegh, S. M. & Brady, S. T. (1990) Slow axonal transport in Trembler mouse: Altered cytoskeletal dynamics in a myelin deficient mouse model. Journal of Neuroscience10, 1855–1865. Google Scholar
De waegh, S. M. & Brady, S. T. (1991) Local control of axonal properties by Schwann cells: Neurofilaments and axonal transport in homologous and heterologous nerve grafts. Journal of Neuroscience Reserch30, 201–212. Google Scholar
De waegh, S. M., Lee, V. M.-Y. & Brady, S. T. (1992) Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell68, 451–463. Google Scholar
Dugandzija-novakovic, S., Koszowski, A. G., Levinson, S. R. & Shrager, P. (1995) Clustering of Na**+** channels and node of Ranvier formation in remyelinating axons. Journal of Neuroscience15, 492–503. Google Scholar
Duncan, I. D., Hammang, J. P. & Trapp, B. D. (1988) Abnormal compact myelin in the myelin-deficient rat: Absence of proteolipid protein correlates with a defect in the intraperiod line. Proceedings of the National Academy of Sciences (USA)84, 6287–6291. Google Scholar
Drescher, K. M., Pease, L. R. & Rodriques, M. (1997) Antiviral immune responses modulate the nature of central nervous system (CNS) disease in a murine model of multiple sclerosis. Immunological Reviews159, 177–193. Google Scholar
Dyck, P. J., Karnes, J. L. & Lambert, E. H. (1989) Longitudinal study of neuropathic deficits and nerve conduction abnormalities in hereditary motor and sensory neuropathy type 1. Neurology39, 1302–1308. Google Scholar
Dyck, P. J., Chance, P., Lebo. R. & Carney, J. A. (1993) Hereditary motor and sensory neuropathies. In Peripheral neuropathy, 3rd ed. (edited by Dyck, P. J., Thomas, P. K., Griffin, J. W., Low, P. A. & Poduslo, J. F.), pp. 1094–1136. Philadelphia: WB Saunders. Google Scholar
Ebers, G. C. & Dyment, D. A. (1998) Genetics of multiple sclerosis. Seminars in Neurology18, 295–299. Google Scholar
Ferguson, B., Matyszak, M. K., Esiri, M. M. & Perry, V. H. (1997) Axonal damage in acute multiple sclerosis lesions. Brain120, 393–399. Google Scholar
Friedman, B., Scherer, S. S., Rudge, J. S., Helgren, M., Morrisey, D., Mcclain, J., Wang, D., Wiegand, S. J., Furth, M. E., Lindsay, R. M. & Ip, N. Y. (1992) Regulation of ciliary neurotrophic factor expression in myelin-related Schwann cells in vivo. Neuron9, 295–305. Google Scholar
Fu, L., Matthews, P. M., De stefano, N., Worsley, K. J., Narayanan, S., Francis, G. S., Antel, J. P., Wolfson, C. & Arnold, D. L. (1998) Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain121, 103–113. Google Scholar
Giese, K. P., Martini, R., Lemke, G., Soriano, P. & Schachner, M. (1992) Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell71, 565–576. Google Scholar
Greenfield, J. G. & King, L. S. (1936) Observations on the histopathology of the cerebral lesions in disseminated sclerosis. Brain59, 445–458. Google Scholar
Griffiths, I. R., Schneider, A., Anderson, J. & Nave, K.-A. (1995) Transgenic and natural mouse models of proteolipid protein (PLP) related dysmyelination and demyelination. Brain Pathology5, 275–281. Google Scholar
Griffiths, I., Klugmann, M., Anderson, T., Yool, D., Thomson, C., Schwab, M. H., Schneider, A., Zimmermann, F., McCulloch, M., Nadon, N. & Nave, K.-A. (1998) Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science280, 1610–1613. Google Scholar
Hafer-macko, C., Hsieh, S.-T., Li, C. Y., Ho, T. W., Sheikh, K., Cornblath, D. R., Mckhann, G. M., Asbury, A. K. & Griffin, J. W. (1996) Acute motor axonal neuropathy: An antibody-mediated attack on axolemma. Annals of Neurology40, 635–644. Google Scholar
Hanemann, C. O. & MÖller, H. W. (1998) Pathogenesis of Charcot-Marie-Tooth IA (CMTIA) neuropathy. Trends in Neuroscience21, 282–286. Google Scholar
Hayasaka, K., Himoro, M., Sato, W., Takada, G., Uyemura, K., Shimizu, N., Bird, T. D., Coneally, P. M. & Chance, P. F. (1993) Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene. Nature Genetics5, 31–34. Google Scholar
Helynck., G., Luu, B., Nussbaum, J. L., Picken, D., Skalidis, G., Trifilieff, E., Van dorsselaer, A., Seta, P., Sandeaux, R., Gavach, C., Heitz, F., Simon, D. & Spach, G. (1983) Brain proteolipids. Isolation, purification and effect on ionic permeability of membranes. European Journal of Biochemistry133, 689–695. Google Scholar
Hildebrand, C., Remahl, S., Persson, H. & Bjartmar, C. (1993) Myelinated nerve fibres in the CNS. Progress in Neurobiology43, 85–141. Google Scholar
Ho, T. W., Mckhann, G. M. & Griffin, J. W. (1998) Human autoimmune neuropathies. Annual Review of Neuroscience21, 187–226. Google Scholar
Hodes, M. E., Pratt, V. M. & Dlouhy, S. R. (1993) Genetics of Pelizaeus-Merzbacher disease. Developmental Neuroscience15, 383–394. Google Scholar
Hohlfeld, R. (1997) Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives [invited review]. BRAIN 120, 865–916. Google Scholar
Inoue, K., Osaka, H., Imaizumi, K., Nezu, A., Takanashi, J., Arii, J., Murayama, K., Ono, J., Kikawa, Y., Mito, T., Shaffer, L. G. & Lupski, J. R. (1999) Proteolipid protein gene duplications causing Pelizaeus-Merzbacher disease: Molecular mechanism and phenotypic manifestations. Annals of Neurology45, 624–632. Google Scholar
Kaplan, M. R., Meyer-franke, A., Lambert, S., Bennett, V., Duncan, I. D., Levison, S. R. & Barres, B. A. (1997) Induction of sodium channel clustering by oligodendrocytes. Nature386, 724–728. Google Scholar
Kidd, D., Thorpe, J. W., Thompson, A. J., Kendall, B. E., Moseley, I. F., Macmanus, D. G., Mcdonald, W. I. & Miller, D. H. (1993) Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology43, 2632–2637. Google Scholar
Kirkpatrick, L. L. & Brady, S. T. (1994) Modulation of the axonal microtubule cytoskeleton by myelinating Schwann cells. Journal of Neuroscience14, 7440–7450. Google Scholar
Kitagawa, K., Sinoway, M. P., Yang, C., Gould, R. M. & Colman, D. R. (1993) A proteolipid protein gene family: expression in sharks and rays and possible evolution from an ancestral gene encoding a poreforming polypeptide. Neuron11, 433–448. Google Scholar
Koo, E. H., Sisodia, S. S., Archer, D. R., Martin, L. J., Weidemann, A., Beyreuther, K., Fischer, P., Masters, C. L. & Price, D. L. (1990) Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proceedings of the National Academy of Sciences (USA)87, 1561–1565. Google Scholar
Lai, C., Brow, M. A., Nave, K.-A., Noronha, A. B., Quarles, R. H., Bloom, F. E., Milner, R. J. & Sutcliffe, J. G. (1987) Two forms of 1B236/myelinassociated glycoprotein (MAG), a cell adhesion molecule for postnatal neural development, are produced by alternative splicing. Proceedings of the National Academy of Sciences (USA)84, 4337–4341. Google Scholar
Li, C., Tropak, M. B., Gerial, R., Clapoff, S., Abramow-newerly, W., Trapp, B., Peterson, A. & Roder, J. (1994) Myelination in the absence of myelin-associated glycoprotein. Nature369, 747–750. Google Scholar
Li, M., Shibata, A., Li, C., Braun, P. E., McKerracher, L., Roder, J., Kater, S. B. & David, S. (1996) Myelin-associated glycoprotein inhibits neurite/axon growth and causes growth cone collapse. Journal of Neuroscience Research46, 404–414. Google Scholar
Linington, C. (1998) Experimental animal models. In Immunotherapy in Neuroimmunologic Diseases, (edited by Zhang, J., Hafler, D., Hohlfeld, R. & Miller, A.), pp. 11–28. London: Martin Dunitz. Google Scholar
Lloyd, K. G. (1977) CNS compensation to dopamine neuron loss in Parkinson's disease. Advances in Experimental Medicine and Biology90, 255–266. Google Scholar
Losseff, N. A., Webb, S. L., O'riordan, J. I., Page, R., Wang, L., Barker, G. J., Tofts, P. S., McDonald, W. I., Miller, D. H. & Thompson, A. J. (1996a) Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain119, 701–708. Google Scholar
Losseff, N. A., Wang, L., Lai, H. M., Yoo, D. S., Gawne-cain, M. L., Mcdonald, W. I., Miller, D. H. & Thompson, A. J. (1996b) Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain119, 2009–2019. Google Scholar
Losseff, N. A. & Miller, D. H. (1998) Measures of brain and spinal cord atrophy in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry64, S102–S105. Google Scholar
Low, P. A. & Mcleod, J. G. (1975) Hereditary demyelination neuropathy in the Trembler mouse. Journal of the Neurological Sciences26, 565–574. Google Scholar
Lublin, F. D. & Reingold, S. C. (1996) Defining the clinical course of multiple sclerosis: results of an international survey. Neurology46, 907–911. Google Scholar
Matthews, P. M., Pioro, E., Narayanan, S., De Stefano, N., Fu, L., Francis, G., Antel, J., Wolfson, C. & Arnold, D. L. (1996) Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. Brain119, 715–722. Google Scholar
Matthews, P. M., De stefano, N., Narayanan, S., Francis, G. S., Wolinsky, J. S., Antel, J. P. & Arnold, D. L. (1998) Putting magnetic resonance spectroscopy studies in context: Axonal damage and disability in multiple sclerosis. Seminars in Neurology18, 327–336. Google Scholar
Mcfarland, H. F., Frank, J. A., Albert, P. S., Smith, M. E., Martin, R., Harris, J. O., Patronas, N., Maloni, H. & Mcfarlin, D. E. (1992) Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Annals of Neurology32, 758–766. Google Scholar
Mckerracher, L., David, S., Jackson, D. L., Kottis, V., Dunn, R. J. & Braun, P. E. (1994) Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron13, 805–811. Google Scholar
Mews, I., Bergmann, M., Bunkowski, S., Gullotta, F. & BrÑck, W. (1998) Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions. Multiple Sclerosis4, 55–62. Google Scholar
Montag, D., Giese, K. P., Bartsch, U., Martini, R., Lang, Y., BlÑthmann, H., Karthigasan, J., Kirschner, D. A., Wintergerst, E. S., Nave, K.-A., Zielasek, J., Toyka, K. V., Lipp, H.-P. & Schachner, M. (1994) Mice deficient for the myelinassociated glycoprotein show subtle abnormalities in myelin. Neuron13, 229–246. Google Scholar
Mukhopadhyay, G., Doherty, P., Walsh, F. S., Crocker, P. R. & Filbin, M. T. (1994) A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron13, 757–767. Google Scholar
Narayanan, S., Fu, L., Pioro, E., De stefano, N., Collins, D. L., Francis, G. S., Antel, J. P., Matthews, P. M. & Arnold, D. L. (1997) Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Annals of Neurology41, 385–391. Google Scholar
Njenga, M. K., Murray, P. D., Mcgavern, D., Lin, X., Drescher, K. M. & Rodriguez, M. (1999) Absence of spontaneous central nervous system remyelination in class II-deficient mice infected with Theiler's virus. Journal of Neuropathology and Experimental Neurology58, 78–91. Google Scholar
Notterpek, L. M. & Rome, L. H. (1994) Functional evidence for the role of axolemma in CNS myelination. Neuron13, 473–485. Google Scholar
Oppenheimer, D. R. (1978) The cervical cord in multiple sclerosis. Neuropathology and Applied Neurobiology4, 151–162. Google Scholar
Owens, T. & Sriram, S. (1995) The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. Neurologic Clinics13, 51–73. Google Scholar
Perkins, S., Aguayo, A. & Bray, G. (1981) Behaviour of Schwann cells from Trembler mouse unmyelinated fibers transplanted into myelinated nerves. Experimental Neurology71, 515–526. Google Scholar
Prineas, J. W. & Mcdonald, W. I. (1997) Demyelinating diseases. In Greenfield's Neuropathology, 6th ed. (edited by Graham, D. I. & Lantos, P. L.), pp. 813–881. International Society of Neuropathology.
Powell, H. C. & Myers, R. R. (1996) The axon in Guillain-Barr, syndrome: Immune target or innocent bystander? Annals of Neurology39, 4–5. Google Scholar
Putnam, T. J. (1936) Studies in multiple sclerosis. Archives of Neurology and Psychiatry35, 1289–1308. Google Scholar
Raine, C. S. (1984) Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Laboratory Investigation50, 608–635. Google Scholar
Raine, C. S. & Cross, A. H. (1989) Axonal dystrophy as a consequence of long-term demyelination. Laboratory Investigation60, 714–725. Google Scholar
Ritchie, J. M. (1984) Physiological basis of conduction in myelinated nerve fibers. In Myelin (edited by Morell, P.), pp. 117–146. New York: Plenum Press. Google Scholar
Rivera-quinones, C., Mcgavern, D., Schmelzer, J. D., Hunter, S. F., Low, P. A. & Rodriguez, M. (1998) Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nature Medicine4, 187–193. Google Scholar
Rodriguez, M., Olezak, E. & Leibowitz, J. (1987) Theiler'smurine encephalomyelitis:Amodel of demyelination and persistence of virus. Critical Reviews in Immunology7, 325–365. Google Scholar
Rosenbluth, J. (1988) Role of glial cells in the differentiation and function of myelinated axons. International Journal of Developmental Neuroscience6, 3–24. Google Scholar
Rudick, R., Cohen, J. A., Weinstock-guttman, B., Kinkel, R. P. & Ransohoff, R. M. (1997) Management of Multiple Sclerosis. New England Journal of Medicine337, 1604–1611. Google Scholar
Sahenk, Z. & Chen, L. (1998) Abnormalities in the axonal cytoskeleton induced by a Connexin32 mutation in nerve xenografts. Journal of Neuroscience Research51, 174–184. Google Scholar
Sahenk, Z., Chen, L. & Mendell, J. R. (1999) Effects of PMP22 duplication and deletions on the axonal cytoskeleton. Annals of Neurology45, 16–24. Google Scholar
Salzer, J. L., Holmes, W. P. & Colman, D. R. (1987) The amino acid sequences of the myelin-associated glycoproteins: homology to the immunoglobulin gene superfamily. Journal of Cell Biology104, 957–965. Google Scholar
Sanchez, I., Hassinger, L., Paskevich, P. A., Shine, H. D. & Nixon, R. A. (1996) Oligodendroglia regulate the regional expansion of axon caliber and local accumulation of neurofilaments during development independently of myelin formation. Journal of Neuroscience16, 5095–5105. Google Scholar
Scherer, S. (1999) Axonal pathology in demyelinating diseases. Annals of Neurology45, 6–7. Google Scholar
Scherer, S. S., Xu, Y. T., Nelles, E., Fischbeck, K. & Bone, L. J. (1998) Connexin32-null mice develop demyelinating peripheral neuropathy. Glia24, 8–20. Google Scholar
Seitelberger, F. (1995) Neuropathology and genetics of Pelizaeus-Merzbacher disease. Brain Pathology5, 267–273. Google Scholar
Sheikh, K. A., Sun, J., Kawai, H., Crawford, T. O., Proia, R. L., Griffin, J. W. & Schnaar, R. L. (1999) Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proceedings of the National Academy of Sciences (USA)96, 7532–7537. Google Scholar
Sternberger, N. H., Quarles, R. H., Itoyama, Y. & Webster, H. D. (1979) Myelin-associated glycoprotein demonstrated immunocytochemically in myelin and myelin forming cells of developing rats. Proceedings of the National Academy of Sciences (USA)76, 1510–1514. Google Scholar
Tasaki, I. (1982) Physiology and Electrochemistry of Nerve Fibers. New York: Academic. Google Scholar
Trapp, B. D., Andrews, S. B., Cootauco, C. & Quarles, R. H. (1989) The myelin-associated glycoprotein is enriched in multivesicular bodies and periaxonal membranes of actively myelinating oligodendrocytes. Journal of Cell Biology109, 2417–2426. Google Scholar
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., MÖrk, S. & BÖ, L. (1998) Axonal transection in the lesions of multiple sclerosis. New England Journal of Medicine338, 278–285. Google Scholar
Trapp, B. D., Ransohoff, R. M., Fisher, E. & Rudick, R. (1999) Neurodegeneration in multiple sclerosis: relationship to neurological disability. The Neuroscientist5, 48–57. Google Scholar
Voyvodic, J. T. (1989) Target size regulates calibre and myelination of sympathetic axons. Nature342, 430–433. Google Scholar
Waxman, S. G. (1998) Demyelinating diseasesÑnew pathological insights, new therapeutic targets. New England Journal of Medicine338, 223–225. Google Scholar
Windenbank, A. J., Wood, P., Bunge, R. P. & Dyck, P. J. (1985) Myelination determines the caliber of dorsal root ganglion neurons in culture. Journal of Neuroscience5, 1563–1569. Google Scholar
Yang, L. J.-S., Zeller, C. B., Shaper, N. L., Kiso, M., Hasegawa, A., Shapiro, R. E. & Schnaar, R. L. (1996) Gangliosides are neuronal ligands for myelin-associated glycoprotein. Proceedings of the National Academy of Sciences (USA)93, 814–818. Google Scholar
Yin, X., Crawford, T. O., Griffin, J. W., Tu, P., Lee, V. M.-Y., Li, C., Roder, J. & Trapp, B. D. (1998) Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. Journal of Neuroscience18, 1953–1963. Google Scholar
Yu, M., Nishiyama, A., Trapp, B. D., Tuohy, V. (1996) Interferon-β inhibits progression of relapsingremitting experimental autoimmune encephalomyelitis. Journal of Neuroimmunology64, 91–100. Google Scholar